[go: up one dir, main page]

BR0009704A - Utilização do osanetant para a preparação de medicamentos úteis no tratamento das perturbações do humor - Google Patents

Utilização do osanetant para a preparação de medicamentos úteis no tratamento das perturbações do humor

Info

Publication number
BR0009704A
BR0009704A BR0009704-7A BR0009704A BR0009704A BR 0009704 A BR0009704 A BR 0009704A BR 0009704 A BR0009704 A BR 0009704A BR 0009704 A BR0009704 A BR 0009704A
Authority
BR
Brazil
Prior art keywords
osanetant
preparation
treatment
mood disorders
drugs useful
Prior art date
Application number
BR0009704-7A
Other languages
English (en)
Inventor
Xavier Emonds-Alt
Philippe Soubrie
Regis Steinberg
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of BR0009704A publication Critical patent/BR0009704A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Patente de Invenção: "UTILIZAçãO DO OSANETANT PARA A PREPARAçãO DE MEDICAMENTOS úTEIS NO TRATAMENTO DAS PERTURBAçõES DO HUMOR". A invenção refere-se à utilização do osanetant e de seus sais farmaceuticamente aceitáveis para a preparação de medicamentos úteis no tratamento das perturbações do humor, em especial a depressão.
BR0009704-7A 1999-04-13 2000-04-11 Utilização do osanetant para a preparação de medicamentos úteis no tratamento das perturbações do humor BR0009704A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904699A FR2792199B3 (fr) 1999-04-13 1999-04-13 Utilisation de l'osanetant pour la preparation de medicaments utiles dans le traitement des troubles de l'humeur
PCT/FR2000/000924 WO2000061125A2 (fr) 1999-04-13 2000-04-11 L'osanetant dans le traitement des troubles de l'humeur

Publications (1)

Publication Number Publication Date
BR0009704A true BR0009704A (pt) 2002-01-08

Family

ID=9544412

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009704-7A BR0009704A (pt) 1999-04-13 2000-04-11 Utilização do osanetant para a preparação de medicamentos úteis no tratamento das perturbações do humor

Country Status (25)

Country Link
US (1) US6420388B1 (pt)
EP (1) EP1175215A2 (pt)
JP (1) JP2002541190A (pt)
KR (1) KR20010105418A (pt)
CN (1) CN1354662A (pt)
AR (1) AR023452A1 (pt)
AU (1) AU3971600A (pt)
BG (1) BG105984A (pt)
BR (1) BR0009704A (pt)
CA (1) CA2369638A1 (pt)
CZ (1) CZ20013645A3 (pt)
EE (1) EE200100527A (pt)
FR (1) FR2792199B3 (pt)
HR (1) HRP20010741A2 (pt)
HU (1) HUP0200655A3 (pt)
ID (1) ID30458A (pt)
IS (1) IS6098A (pt)
MX (1) MXPA01010340A (pt)
NO (1) NO20014953L (pt)
PE (1) PE20010032A1 (pt)
PL (1) PL351554A1 (pt)
SK (1) SK14552001A3 (pt)
TR (1) TR200102930T2 (pt)
WO (1) WO2000061125A2 (pt)
ZA (1) ZA200108289B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001275524B2 (en) * 2000-06-12 2006-02-02 University Of Rochester Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist
KR101150548B1 (ko) * 2003-12-22 2012-07-06 글락소 그룹 리미티드 신경학적 질환을 치료하기 위한 ｎｏｇｏ-ａ 중화면역글로불린
JP2007530591A (ja) * 2004-03-25 2007-11-01 スミスクライン・ビーチャム・コーポレイション 双極性障害を治療するための、ｎｋ３アンタゴニストの使用
EP1867717A4 (en) * 2005-03-15 2008-08-20 Sumitomo Chemical Co METHOD FOR ENHANCING SYMPTOMS FROM MOOD DISORDERS
JP2006320201A (ja) * 2005-05-17 2006-11-30 Sumitomo Chemical Co Ltd 気分障害又は関連障害による疾患症状を改善させる方法
GB0525662D0 (en) 2005-12-16 2006-01-25 Glaxo Group Ltd Immunoglobulins
EP3915560A1 (en) 2014-06-25 2021-12-01 Emory University Methods of managing conditioned fear with neurokinin receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2738819B1 (fr) 1995-09-14 1997-12-05 Sanofi Sa Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant
WO1998011090A2 (en) 1996-09-16 1998-03-19 Warner-Lambert Company 3-alkyl-3-phenyl-piperidines

Also Published As

Publication number Publication date
NO20014953D0 (no) 2001-10-11
AU3971600A (en) 2000-11-14
EE200100527A (et) 2002-12-16
WO2000061125A3 (fr) 2001-04-19
CN1354662A (zh) 2002-06-19
MXPA01010340A (es) 2002-05-06
PE20010032A1 (es) 2001-04-11
IS6098A (is) 2001-09-28
HUP0200655A2 (hu) 2002-07-29
HUP0200655A3 (en) 2002-11-28
US6420388B1 (en) 2002-07-16
ID30458A (id) 2001-12-06
WO2000061125A2 (fr) 2000-10-19
CZ20013645A3 (cs) 2002-01-16
TR200102930T2 (tr) 2002-04-22
ZA200108289B (en) 2002-12-24
KR20010105418A (ko) 2001-11-28
HRP20010741A2 (en) 2002-10-31
FR2792199A1 (fr) 2000-10-20
BG105984A (bg) 2002-04-30
NO20014953L (no) 2001-12-11
AR023452A1 (es) 2002-09-04
PL351554A1 (en) 2003-05-05
FR2792199B3 (fr) 2001-05-18
SK14552001A3 (sk) 2002-02-05
EP1175215A2 (fr) 2002-01-30
CA2369638A1 (en) 2000-10-19
JP2002541190A (ja) 2002-12-03

Similar Documents

Publication Publication Date Title
BR0010498A (pt) Composições modernas de medicamentos à base de compostos anticolinergicamente ativos e beta-miméticos
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
CY1105707T1 (el) Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου
EE200200274A (et) Pürrolidiinatseetamiidi derivaadi kasutamine ravimi valmistamiseks, mis on ette nähtud kesknärvisüsteemi häirete ravimiseks, ja farmatseutiline kompositsioon
RS50876B (sr) Upotreba flibanserina u lečenju seksualnih poremećaja
BR0113331A (pt) Derivados de fenilalanina ou seus sais parmaceuticamente aceitáveis, antagonista de integrina alfa 4, agente terapêutico ou agente preventivo para doenças inflamatórias, e, composição farmacêutica
BR0109272A (pt) Agentes conjugados terapêuticos de ácido poliglutâmico, métodos para suas preparações e usos
DE69831869D1 (de) Verbesserte verabreichungstechnik für multiple medikamentengaben
HUP0300426A2 (hu) Antihipertenzív és anti-angiogén szerek terápiás kombinációja és ezeket tartalmazó gyógyszerkészítmények
BR0308739A (pt) Tratamentos em combinação para doenças mediadas por quimiocina
BR0008699A (pt) Combinações de formoterol e furoato demometasona para asma
BR9807673A (pt) Processos para tratar asma alérgica e dermatite em um humano e composição farmacêutica.
WO2003009838A1 (fr) Utilisation de composes de stilbene dans la preparation de medicaments pour le traitement ou la prevention du diabete et des maladies associees au retrovirus
GEP20033090B (en) Derivatives of Acyl-Piperazinil-Pyrimidins, Preparation, Method for Their Preparation and Their Application
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
BR0010006A (pt) Utilização do saredutante e de seus sais farmaceuticamente aceitáveis para o preparo de medicamentos úteis no tratamento ou na prevenção do conjunto das perturbações do humor, das perturbações da adaptação ou das perturbações mistas ansiedade-depressão
EE04493B1 (et) Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks
BRPI0408295A (pt) uso de um composto
AR023687A1 (es) Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa
BR9810337A (pt) Utilização de um antagonista especìfico dos receptores 5ht2 para a preparação de medicamentos úteis no tratamento da sìndrome de apnéia do sono
BR0009704A (pt) Utilização do osanetant para a preparação de medicamentos úteis no tratamento das perturbações do humor
DE69918961D1 (de) Verbesserte inhalationspräparate
BR0008703A (pt) Utilização da tianeptina para a obtenção de medicamentos destinados ao tratamento das patologias da neurodegenerescência
EE200100689A (et) IL6RIL6 kimääri kasutamine ravimi valmistamiseks,mis on ette nähtud neuroloogiliste haiguste ravimiseks, ning farmatseutiline kompositsioon
WO1997005864A3 (en) Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]